Boxer Capital, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Boxer Capital, LLC

  • $1.8 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$10.39 - $15.15 $3.02 Million - $4.4 Million
-290,577 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$16.25 - $28.09 $14.3 Million - $24.8 Million
-882,123 Reduced 75.22%
290,577 $8.16 Million
Q2 2018

Aug 14, 2018
BUY
$16.73 - $20.35 $19.6 Million - $23.9 Million
1,172,700 New
1,172,700 $20.3 Million

Others Institutions Holding KNSA

# of Institutions
11
Shares Held
1.89M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $862M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email